Myelodysplastic Syndromes Treatment

Considered To Be A Collection Of Blood Disorders As Well As A Type Of Cancer, MDS Behaves Similarly To Other Blood Cancers. The Production Of Numerous Blood Cell Types, In Addition To Stem Cells Which Are Primarily Affected By MDS, Are Reduced Due To The Accumulation Of Abnormal And Immature Cancer Cells In The Bone Marrow.

Some Myelodysplastic Syndromes May Also Develop Into A Different Kind Of Blood Cancer Known As Acute Myeloid Leukemia.

The causes of MDS are not fully understood, but several risk factors have been identified, and there are some known genetic mutations that are associated with the development of this condition.

Myelodysplastic Syndromes (MDS) Causes

• Age: The risk of developing MDS increases with age, and it is most commonly diagnosed in individuals over the age of 60.
• Exposure to toxins: Exposure to certain chemicals, such as benzene or pesticides, may increase the risk of developing MDS.
• Radiation therapy or chemotherapy: Previous treatment with radiation therapy or chemotherapy may increase the risk of developing MDS.
• Genetic mutations: Some genetic mutations, such as those in the TP53 or SF3B1 genes, have been associated with the development of MDS.

Myelodysplastic Syndromes (MDS) Symptoms

The symptoms of MDS may vary depending on the type and severity of the blood disorder. Some common symptoms include:

• Fatigue: MDS can cause fatigue and weakness, even with minimal activity.
• Shortness of breath: MDS can cause a low red blood cell count, which can lead to shortness of breath and dizziness.
• Pale skin: MDS can cause a low red blood cell count, which can cause the skin to appear pale.
• Infections: MDS can cause a low white blood cell count, which can increase the risk of infections.
• Bleeding and bruising: MDS can cause a low platelet count, which can increase the risk of bleeding and bruising.
• Enlarged spleen: MDS can cause the spleen to enlarge, which can cause discomfort or pain in the left upper abdomen.